The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

 
Web www.patentalert.com

> Compounds, compositions and methods for the treatment of synucleinopathies

~ 00396